Keunpyo Kim

1.4k total citations · 1 hit paper
22 papers, 1.1k citations indexed

About

Keunpyo Kim is a scholar working on Physiology, Molecular Biology and Genetics. According to data from OpenAlex, Keunpyo Kim has authored 22 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Physiology, 6 papers in Molecular Biology and 5 papers in Genetics. Recurrent topics in Keunpyo Kim's work include Advanced Statistical Process Monitoring (5 papers), Hemoglobinopathies and Related Disorders (5 papers) and Asthma and respiratory diseases (5 papers). Keunpyo Kim is often cited by papers focused on Advanced Statistical Process Monitoring (5 papers), Hemoglobinopathies and Related Disorders (5 papers) and Asthma and respiratory diseases (5 papers). Keunpyo Kim collaborates with scholars based in United States, Netherlands and Canada. Keunpyo Kim's co-authors include William H. Woodall, Mahmoud A. Mahmoud, Néstor A. Molfino, Marion R. Reynolds, Faiz Ahmad Khan, Brian H. Rowe, Joseph M. Parker, Howard Smithline, Robert A. Silverman and Kimmie McLaurin and has published in prestigious journals such as New England Journal of Medicine, Blood and CHEST Journal.

In The Last Decade

Keunpyo Kim

20 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gene Editing for CEP290 -Associated Retinal Degeneration

2024 86 citations Tomás S. Alemán, Thiran Jayasundera et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Keunpyo Kim

Since Specialization

Citations

This map shows the geographic impact of Keunpyo Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keunpyo Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keunpyo Kim more than expected).

Fields of papers citing papers by Keunpyo Kim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keunpyo Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keunpyo Kim. The network helps show where Keunpyo Kim may publish in the future.

Co-authorship network of co-authors of Keunpyo Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Keunpyo Kim. A scholar is included among the top collaborators of Keunpyo Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keunpyo Kim. Keunpyo Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Reni-Cel, an Investigational AsCas12a Gene-Edited Cell Medicine, Led to Successful Engraftment, Increased Hemoglobin, and Reduced Transfusion Dependence in Patients with Transfusion-Dependent Beta-Thalassemia Treated in the Edithal Trial 2025 ·Transplantation and Cellular Therapy ·Haydar Frangoul, (unknown), (unknown), Kai‐Hsin Chang, Michael Jaskolka, Keunpyo Kim, Baisong Mei, Olubunmi Afonja, Alexis A. Thompson	0
2	Gene Editing for CEP290 -Associated Retinal Degeneration breakdown → 2024 ·New England Journal of Medicine ·(unknown), Tomás S. Alemán, Thiran Jayasundera, (unknown), Keunpyo Kim, (unknown), Michael Jaskolka, (unknown), (unknown), Steven T. Bailey, Jason Comander, Andreas Lauer, Albert M. Maguire, Mark E. Pennesi	86
3	Reni-Cel, an Investigational AsCas12a Gene-Edited Cell Medicine, Led to Successful Engraftment, Increased Hemoglobin, and Reduced Transfusion Dependence in Patients with Transfusion-Dependent Beta-Thalassemia Treated in the Edithal Trial 2024 ·Blood ·Haydar Frangoul, (unknown), Mark C. Walters, Kai‐Hsin Chang, Michael Jaskolka, Keunpyo Kim, Baisong Mei, Olubunmi Afonja, Alexis A. Thompson	0
4	Twelve-month Natural History Study of Centrosomal Protein 290 (CEP290)-associated Inherited Retinal Degeneration 2024 ·Ophthalmology Science ·Eric A. Pierce, (unknown), Thiran Jayasundera, Carel B. Hoyng, (unknown), Birgit Lorenz, Keunpyo Kim, (unknown), (unknown), Mark E. Pennesi	5
5	AsCas12a Gene Editing of HBG1/2 Promoters with Edit-301 Results in Early and Sustained Normalization of Hemoglobin and Increased Fetal Hemoglobin in Patients with Severe Sickle Cell Disease and Transfusion-Dependent Beta-Thalassemia 2024 ·Transplantation and Cellular Therapy ·Haydar Frangoul, (unknown), Christopher McKinney, Luis Piñeiro, Markus Y. Mapara, Jignesh Dalal, Kai‐Hsin Chang, Michael Jaskolka, Keunpyo Kim, Daphne L. Farrington, (unknown), Baisong Mei, (unknown), Olubunmi Afonja, Mark C. Walters	5
6	AsCas12a Gene Editing of HBG1/2 Promoters with EDIT-301 Results in Rapid and Sustained Normalization of Hemoglobin and Increased Fetal Hemoglobin in Patients with Severe Sickle Cell Disease and Transfusion-Dependent Beta-Thalassemia 2023 ·Blood ·(unknown), Haydar Frangoul, Christopher McKinney, Luis Piñeiro, Markus Y. Mapara, Jignesh Dalal, Kai‐Hsin Chang, Michael Jaskolka, Keunpyo Kim, Daphne L. Farrington, (unknown), Baisong Mei, (unknown), Olubunmi Afonja, Mark C. Walters	11
7	Symmetric Age Association of Retinal Degeneration in Patients with CLN2-Associated Batten Disease 2020 ·Ophthalmology Retina ·Kyle D. Kovacs, Samir C. Patel, Anton Orlin, Keunpyo Kim, Sherri Van Everen, (unknown), Dolan Sondhi, Stephen M. Kaminsky, Donald J. D’Amico, Ronald G. Crystal, Szilárd Kiss	19
8	Pharmacokinetics, Pharmacodynamics, and Safety of MEDI4212, an Anti-IgE Monoclonal Antibody, in Subjects with Atopy: A Phase I Study 2016 ·Advances in Therapy ·Eric Sheldon, Martin Schwickart, Jing Li, Keunpyo Kim, (unknown), Shaista Parveen, Chris Kell, Claire Birrell	36
9	A randomized trial of benralizumab, an antiinterleukin 5 receptor α monoclonal antibody, after acute asthma 2014 ·The American Journal of Emergency Medicine ·Richard M. Nowak, Joseph M. Parker, Robert A. Silverman, Brian H. Rowe, Howard Smithline, Faiz Ahmad Khan, (unknown), Keunpyo Kim, Néstor A. Molfino	155
10	A randomized, controlled trial to evaluate the effect of an anti-interleukin-9 monoclonal antibody in adults with uncontrolled asthma 2013 ·Respiratory Research ·Chad K. Oh, Richard Leigh, Kimmie McLaurin, Keunpyo Kim, Micki Hultquist, Néstor A. Molfino	101
11	A Phase 2b, Randomized Study To Evaluate The Clinical Activity And Safety Profile Of Subcutaneous MEDI-528, An Anti-IL-9 Monoclonal Antibody, In Adults With Uncontrolled Asthma 2012 ·Chad K. Oh, Kimmie McLaurin, Keunpyo Kim, Micki Hultquist, Néstor A. Molfino	2
12	Characteristics and 12-Week Outcomes for Marijuana Smokers in Subjects With Asthma Treated in the Emergency Department for an Asthma Exacerbatio 2012 ·CHEST Journal ·Joseph M. Parker, Keunpyo Kim, Robert A. Silverman, Kimmie McLaurin, (unknown), Néstor A. Molfino	1
13	Reduction In The Number And Severity Of Exacerbations Following Acute Severe Asthma: Results Of A Placebo-Controlled, Randomized Clinical Trial With Benralizumab 2012 ·Néstor A. Molfino, Richard J. Nowak, Robert A. Silverman, Brian H. Rowe, Howard Smithline, Faiz Ahmad Khan, (unknown), Keunpyo Kim, Joseph M. Parker	9
14	A Comparative Lipidomics Platform for Chemotaxonomic Analysis of Mycobacterium tuberculosis 2011 ·Chemistry & Biology ·Emilie Layre, Lindsay Sweet, Sun Hee Hong, Cressida A. Madigan, Danielle Desjardins, David C. Young, Tan‐Yun Cheng, John W. Annand, Keunpyo Kim, Isdore Chola Shamputa, Matthew McConnell, (unknown), Samuel M. Behar, Adriaan J. Minnaard, Megan Murray, Clifton E. Barry, Isamu Matsunaga, D. Branch Moody	141
15	Multivariate Control Charts for Monitoring the Process Mean and Variability Using Sequential Sampling 2007 ·Sequential Analysis ·Marion R. Reynolds, Keunpyo Kim	25
16	Multivariate monitoring using an MEWMA control chart with unequal sample sizes 2006 ·Quality Engineering ·Keunpyo Kim, Marion R. Reynolds	1
17	Multivariate Monitoring Using an MEWMA Control Chart with Unequal Sample Sizes 2005 ·Journal of Quality Technology ·Keunpyo Kim, Marion R. Reynolds	18
18	Multivariate Monitoring of the Process Mean Vector with Sequential Sampling 2005 ·Journal of Quality Technology ·Marion R. Reynolds, Keunpyo Kim	23
19	A comparative study of user performance in a map-based virtual environment 2003 ·J. Edward Swan, Joseph L. Gabbard, Deborah Hix, Robert S. Schulman, Keunpyo Kim	22
20	Long-term stability of nutrients in a frozen mixed food control material 2001 ·Fresenius Journal of Analytical Chemistry ·Katherine M. Phillips, A Simpkins, (unknown), (unknown), Kent K. Stewart, (unknown), Keunpyo Kim, Gary R. Beecher, Joanne M. Holden	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact